Ledger.Open graph →
SEC Form D · filed March 21, 2024

GlycosBio Inc

Offering
$5.0M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Houston, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Victoria C. Niklas · Houston, TXDirectorJoseph C. Walowski · Houston, TXDirectorFrank C. Foster · Santa Barbara, CADirectorJohn C. Replogle · Raleigh, NCDirectorRichard C. Cilento · Houston, TXExec · DirectorSusan Uthayakumar · Toronto, Ontario, CanadaDirectorDavid Stetson · Toronto, Ontario, CanadaDirectorJohn Pollesel · Toronto, Ontario, CanadaDirectorNic Pannekeet · Seattle, WADirectorSusumu J. Kodera · Irvine, CADirectorWayne Byrne · Seattle, WADirectorJohn C. Replogle · Raleigh, NCDirectorRichard C. Cilento · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗